Lifevantage (NASDAQ: LFVN) reported Q4 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $45.3 million versus the consensus estimate of $45.1 million.

Lifevantage sees FY2016 EPS of $0.08-$0.11, versus the consensus of $0.10. Lifevantage sees FY2016 revenue of $195-210 million, versus the consensus of $188.6 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.